Oxidative stress-mediated apoptosis of renal tubular cells is a major pathology 2 of gentamicin-induced nephrotoxicity which is one of the prevailing causes of acute 3 renal failure. Pinocembrin is a major flavonoid found in rhizomes of fingerroot 4 (Boesenbergia pandurata). It has pharmacological and biological activities including 5 antimicrobial, anti-inflammatory, and antioxidant effects. Preclinical studies have 6 suggested that pinocembrin protects rat brain and heart against oxidation and apoptosis 7 induced by ischemia-reperfusion model. The aim of the current study was to investigate 8 the mechanisms of renoprotection elicited by pinocembrin in gentamicin-induced 9 nephrotoxicity. Nephrotoxic rats were induced by intraperitoneal injection (i.p) of 10 gentamicin and pinocembrin was administered via i.p. 30 min before gentamicin 11 treatment for 10 days. Gentamicin-induced nephrotoxicity was indicated by the reduced 12 renal function and renal Oat3 function and expression. Gentamicin treatment also 13 stimulated Nrf2, HO-1, and NQO1 and the pro-apoptotic protein, Bax and caspase-3, 14 concomitant with the attenuation of Bcl-XL expressions in the renal cortical tissues. 15
ethanol to obtain pinocembrin (69.32 mg). Finally, structural confirmation was 24 performed using UV, FTIR, 1H NMR, 13C NMR, MS. The purity of pinocembrin was 25 more than 95% (Charoensin et al. 2010) . 26
Previous study investigated the toxicity dose of pinocembrin in a rat model 27 (Charoensin et al. 2010 ). Pinocembrin at the doses of 1-100 mg/kg and 500 mg/kg were 28 administrated by gavage feeding. There were neither toxic nor death in rats studied in 29 D r a f t that model. Recently, there was a report in a double-blind, placebo-controlled, 1 randomized study carried out in 58 healthy subjects (Cao et al. 2015) . Single ascending 2 doses of pinocembrin (20-150 mg) as well as multidose study at 60-mg pinocembrin 3 were investigated. The results showed that pinocembrin was well tolerated and no 4 serious adverse events occurred. No subjects were discontinued because of a treatment 5 emergent AE. These findings indicated that there was no lethal or toxic dose of 6 pinocembrin. 7
Animals 8
Male Sprague-Dawley rats (240-250 g) from the National Laboratory Animal 9
Centre, Mahidol University, Salaya, Nakornpathom were housed in the animal room at 10 controlled temperatures in a 12:12 h light/dark cycle and fed with a normal pellet diet 11 and water ad libitum. This study was carried out in strict accordance with the 12 recommendations in the Guide for the Care and Use of Laboratory Animals of the 13 National Institutes of Health. The protocol was approved by the Committee on the 14
Ethics of Animal Experiments of the Faculty of Medicine, Chiang Mai University 15 (Permit Number: 13/2557). All surgery was performed under sodium pentobarbital 16 anesthesia, and all efforts were made to minimize suffering. 17
Experimental design 18
The rats were randomly divided into 5 groups (6 rats per group) and treated for 19 10 days, as follows:-(1) Control group: the rats were injected intraperitoneally (i.p.) 20 with Tween 80, (2) Gentamicin group: the rats were treated (i.p.) with gentamicin at a 21 dose of 100 mg/kg/day, (3) Pinocembrin plus Gentamicin group: the rats were injected 22 (i.p.) with pinocembrin (dissolved in Tween 80 at a dose of 50 mg/⋅kg/day, obtained 23 from air-dried finger-root weighing 140 g) 30 min prior to the injection of gentamicin, 24 (4) Pinocembrin-50 group: the rats were injected i.p. with pinocembrin (50 mg/kg/day) 25 for 10 days and (5) Pinocembrin-75 group: the rats were injected i.p. with pinocembrin 26 (75 mg/kg/day) for 10 days. The dose of pinocembrin used in this study was chosen 27 from our preliminary experiment and from a previous study (Soromou et al. 2012) . 28
After the treatment on 10 th day, the animals were placed into individual 1 metabolic cage for 24 h urine collection and then sacrificed under anesthesia for blood 2 collection from the right atrium. The kidneys were immediately removed, decapsulated, 3 and weighed. One of the kidneys was divided into two longitudinal sections. Renal 4 cortical tissues were isolated and kept for western blot analysis and evaluation of MDA. 5
The other kidney was perfused with cold PBS, and then cut into two longitudinal 6 sections; one half was fixed in 10% neutralized formalin for further morphological 7 analysis and the other half, the renal cortical tissues were isolated and kept for SOD 8 determination. Then, the tissue samples were placed in liquid nitrogen and stored at -80 9 ºC until use. 10
Determination of renal function 11
The serum and urine creatinine and serum BUN levels were measured by 12 following enzymatic colorimetric methods using commercial kits. The data were 13 expressed as mg/dL.The estimation of glomerular filtration rate (GFR) or creatinine 14 clearance (C cr ) was carried out using the following equation: 15 C cr (mL/min) = urine creatinine X urine flow rate 16
Serum creatinine 17 18

Determination of renal Oat3 function 19
The uptake of radiolabeled estrone sulfate ([ 3 H]ES), a specific Oat3 substrate, 20 into the renal cortical slice, which reflects the renal Oat3 function, was examined. After 21 the animals were sacrificed, the kidneys were removed, decapsulated and placed in 22 freshly oxygenated ice-cold modified Cross and Taggart saline buffer (containing the 23 following: 95 mM NaCl, 80 mM mannitol, 5 mM KCl,0.74 mM CaCl 2 , and 9.5 mM 24 Na 2 HPO 4 , pH 7.4). Thin renal cortical slices (≤ 0.5 mm; 5-15 mg/slice, wet weight) 25
were cut with a Stadie-Riggs microtome and were pre-incubated in modified Cross and 26 Taggart buffer for 10 min then incubated in 1 mL of buffer containing 50 nM [ 3 
H]ES 27
for 30 min at room temperature. At the end of the uptake period, the slices were washed 28 in 0.1 M MgCl 2 , blotted on filter paper, weighed, and dissolved in 0.5 mL of 1 M NaOH 29 D r a f t 8 and then the preparation was neutralized with 0.5 mL of 1N HCl. The radioactivity was 1 measured using a liquid scintillation analyzer (PerkinElmer, MA, USA). The [ 3 H]ES 2 uptake was calculated as tissue to medium (T/M) ratio (dpm/g tissue÷dpm/mL 3 medium). 4
Tissue preparation for western blot analysis 5
Renal cortical tissue, 0.1 g, was chopped and homogenized on ice in 6
Mammalian cell Lytic buffer with a protease inhibitor cocktail. Each cellular 7 component, whole cell lysate, membrane, and cytosolic fraction, were prepared from 8 renal cortical slices using differential centrifugation as previously described 9 (Lungkaphin et al. 2014). Briefly, the homogenate was centrifuged at 5,000x g for 10 10 min at 4 ºC, the supernatant was designated as whole cell lysate, and then the 11 supernatant was further centrifuged at 100,000x g for 2 h at 4 ºC to obtain a membrane 12 (pellet) and cytosolic (supernatant) fractions. The 5,000x g pellet was re-suspended and 13 centrifuged at 10,000x g 4 ºC for 10 min. The supernatant fraction from the spin was 14 designated as the nuclear fraction. All the fractions collected were stored at -80 ºC until 15
use. 16
Determination of renal Oat3 expression 17
The total cell lysates and the membrane fractions from the renal cortex were 18 subjected to SDS-PAGE, and subsequently transferred to a PVDF membrane, as 19 described above. Primary Oat3 antibody at concentration of 1:500 was added. To 20 confirm the enrichment of the membrane fraction, the Na + -K + -ATPase expression was 21 determined as a membrane fraction marker. The density of the protein signal on 22
Hyperfilm was analyzed using the histogram function of Adobe Photoshop CS5 (Adobe 23
Corp., CA, USA) scanning. The protein level was normalized by β-actin as a loading 24 control. 25
Determination of renal lipid peroxidation 26
In order to determine conditions of renal oxidative stress, the measurement of 27 malondialdehyde (MDA) level, a marker of lipid peroxidation, in the renal cortical 28 D r a f t tissues was carried out. Briefly, the renal cortical tissues were cut and suspended in 1
CelLyticMT mammalian tissue lysis/extraction reagent containing a 1% complete 2 protease inhibitor cocktail, made according to the manufacturer's protocol. The tissues 3
were then homogenized and centrifuged at 1,600 g for 10 min at 4 ºC. The supernatants 4
were collected for the determination of MDA concentration using a commercial 5 TBARS assay kit, as previously described (Ohkawa et al. 1979) . Each sample was 6 expressed as total MDA level to total protein concentration (nmol/mg protein). 7
Determination of renal cortical superoxide dismutase (SOD) activity 8
The renal cortex tissue was homogenized at 5 mL/g in cold lysis buffer (50 mM 9 potassium phosphate, 0.1 mM EDTA, 0.5% Triton X-100) and centrifuged at 12,000 g 10 for 5 min at 4ºC. The supernatants were used for total SOD activity determination, 11 according to the manufacturer's protocol. 12
Determination of renal oxidative stress and apoptosis 13
The renal oxidative stress pathway and apoptosis protein markers were 14 determined by western blot analysis. The renal cortical fraction was used to determine 15 the protein expression of PKCα, Nrf2, heme oxygenase-1 (HO-1), NAD(P)H 16 dehydrogenase quinine 1 (NQO1), NADPH oxidase (NOX4), Bax, Bcl-XL and 17 caspase-3. The whole cell fraction was used to determine the PKCα, HO-1, NQO1, 18 NOX4, caspase-3 and the Bcl-2 protein family (pro-apoptotic; Bax and anti-apoptotic; 19
Bcl-XL proteins) expressions by western blot analysis as described above. Briefly, total 20 cell lysates, cytosolic, membrane and nuclear fractions from the renal cortex were 21 subjected to 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and 
Statistical analysis 17
The data are expressed as mean ± standard error of mean (S.E.M) and analyzed 18 using the SPSS version 17 statistical program (SPSS Inc., Chicago, IL, USA). One-way 19 analysis of variance (ANOVA), followed by the Newman-Keuls test, was performed. A 20 P value < 0.05 was considered statistically significant. 21
Results
22
The effect of pinocembrin pretreatment on physiological and renal function parameters 23 in the gentamicin-induced nephrotoxicity 24
There was no difference in the mean initial body weight between the 25 experimental groups. After 10 day of treatment, the gentamicin-treated rats had 26 significantly lower body weights, and markedly higher kidney weight as well as higher 27 D r a f t kidney weight per body weight ratio than those of the control rats (P< 0.05) ( Table 1) The renal cortical MDA was increased in the gentamicin-treated rats in relation 3 to that of the control rats (P< 0.05) (Fig. 3A ). An apparent decrease of MDA to normal 4 level in the pinocembrin plus gentamicin group (P< 0.05) indicated that a marked 5 generation of oxidative stress by gentamicin is significantly prevented by pinocembrin 6 pretreatment. The result of SOD activity was consistent with the previous studies, 7
demonstrating that gentamicin-treated rats had significant decrease in the SOD activity 8 as compared with the control rats (P< 0.05) (Fig. 3B) . Surprisingly, pinocembrin 9 pretreatment could not improve the activity of the SOD enzyme when compared with 10 the gentamicin-treated group. 11
The effect of pinocembrin pretreatment on the oxidative stress pathways in the 12
gentamicin-induced nephrotoxicity 13
Based on previous findings that PKCα was activated by the overproduction of 14 ROS, we determined whether an increased oxidative stress in the renal cortical tissue by 15 gentamicin could activate PKCα. As shown in Fig. 4A , the gentamicin-treated rats 16 significantly enhanced PKCα expression when compared with the control rats (P< 17 0.05), and this increased PKCα expression was significantly reduced by pinocembrin 18 pretreatment (P< 0.05). These findings indicate that the overproduction of ROS in 19 gentamicin-treated rats activates PKCα signaling pathways, and pinocembrin can 20 attenuate the production of ROS and consequently inactivate PKCα. We found that 21 NOX4 expression was stimulated in gentamicin-treated rats (P< 0.05). The treatment 22 with pinocembrin could inhibit NOX4 expression as compared to the gentamicin-treated 23 rats (P< 0.05) (Fig. 4B) . 24
Nrf2, the transcription factor that promotes the antioxidant defense system or 25 protects against oxidative stress, has been shown to protect against gentamicin-induced 26 hair cell damage. Thus, we postulated that an increased oxidative stress in gentamicin-27 treated rats may activate the Nrf2 and Nrf2-mediated antioxidant enzymes. As shown in 28 Fig. 5A and B, the Nrf2 expression in the nuclear fraction of the renal cortical tissue 29 D r a f t 13 was significantly increased in the gentamicin-treated rats when compared with the 1 control rats (P< 0.05). However, there was no change in the Nrf2 expression in the 2 cytosol fraction between the experimental groups. These results suggest that the 3 activation of Nrf2 leads to an increased translocation of Nrf2 from the cytoplasm to the 4 nucleus in gentamicin-treated rats. Interestingly, the nuclear expression of Nrf2 was 5 reduced (P< 0.05) in the pinocembrin plus gentamicin-treated rats compared to the 6 gentamicin-treated rats. Additionally, the expressions of the antioxidant enzyme and the 7 detoxification gene, HO-1 and NQO1, respectively, were apparently increased (P< 8 0.05) in the gentamicin-treated rats as compared with the control rats ( Fig. 5C and D) . 9
Importantly, the increased HO-1 and NQO1 expressions were significantly reduced by 10 pinocembrin pretreatment (P< 0.05). These results suggest that pinocembrin 11 pretreatment can lessen the oxidative stress conditions induced by gentamicin through 12 the modulation of the antioxidant defense parameters. 13
The effect of pinocembrin on renal apoptosis in the gentamicin-induced nephrotoxicity 14
The gentamicin-treated rats demonstrated an increase in the expression of the pro-15 apoptotic protein, Bax, along with a decreased expression of the anti-apoptotic protein, 16
Bcl-XL when compared with the control rats (P< 0.05) (Fig. 6A, B and C) . Pinocembrin 17 pretreatment significantly reversed an altered expression of the apoptosis-related protein 18 in the gentamicin-treated rats (P< 0.05). We found that caspase-3 expression was 19 increased in the gentamicin-treated rats (P< 0.05). Pinocembrin treatment could reverse 20 this effect by reducing the level of caspase-3 as compared to the gentamicin-treated rats 21 (P< 0.05) (Fig. 6D) . 
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